RecruitingNCT07780890
A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Sponsor
Massachusetts General Hospital
Enrollment
90 participants
Start Date
Aug 18, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.
Eligibility
Min Age: 20 YearsMax Age: 79 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with dry eye disease (ded), fuchs endothelial corneal dysfunction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 79 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07780890
Related Trials
BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber
NCT074307351 location
iDose TR Administration in an Office-Based Surgery Setting
NCT07816692
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
NCT0754863214 locations
The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free
NCT07745062
TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)
NCT07732010